TORONTO -- (MARKET WIRE) -- 06/08/2006 -- Generex Biotechnology Corporation (NASDAQ: GNBT) announced today that Dr. Eric von Hofe, Ph.D., President of Antigen Express, Inc., its wholly owned subsidiary, made a presentation of the Company's overall peptide vaccine technology and the status of its pandemic avian influenza virus vaccine program at an international conference in San Diego. At a separate meeting in Atlanta, representatives from the Walter Reed Army Medical Center, working with Dr. George Peoples, presented results from ongoing breast cancer trials being conducted with another Antigen Express peptide vaccine.
